Predicting cancer-associated anaemia in patients receiving non-platinum chemotherapy: results of a retrospective survey
- 30 September 2001
- journal article
- research article
- Published by Elsevier in European Journal Of Cancer
- Vol. 37 (13), 1617-1623
- https://doi.org/10.1016/s0959-8049(01)00169-1
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Clinical Evaluation of Once-Weekly Dosing of Epoetin Alfa in Chemotherapy Patients: Improvements in Hemoglobin and Quality of Life Are Similar to Three-Times-Weekly DosingJournal of Clinical Oncology, 2001
- Chemotherapy-Induced Anemia in Adults: Incidence and TreatmentJNCI Journal of the National Cancer Institute, 1999
- Transfusion Medicine — Blood TransfusionNew England Journal of Medicine, 1999
- Quality-of-life benefit in chemotherapy patients treated with epoetin alfa is independent of disease response or tumor type: results from a prospective community oncology study. Procrit Study Group.Journal of Clinical Oncology, 1998
- Erythropoietin Treatment under Polychemotherapy in Patients with Gynecologic Malignancies: A Prospective, Randomized, Double-Blind Placebo-Controlled Multicenter StudyGynecologic Oncology, 1997
- Impact of therapy with epoetin alfa on clinical outcomes in patients with nonmyeloid malignancies during cancer chemotherapy in community oncology practice. Procrit Study Group.Journal of Clinical Oncology, 1997
- Erythropoietin for anaemia in cancer patientsEuropean Journal Of Cancer, 1993
- Recombinant Human Erythropoietin Therapy for Anemic Cancer Patients on Combination ChemotherapyJNCI Journal of the National Cancer Institute, 1993
- Use of blood transfusion in management of anemiaMedical Clinics of North America, 1992
- Special Report: Transfusion RisksAmerican Journal of Clinical Pathology, 1987